HYPR Share Price Performance
US$1.03
0.05 (5.06%)
37.9% undervalued intrinsic discount
US$1.65
Fair Value
Price US$1.03
AnalystConsensusTarget US$1.65
AnalystHighTarget US$2.00
AnalystLowTarget US$0.85
Fair ValueUS$1.65
Share Pricen/a
Hyperfine, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 8 Fair Values set on narratives written by author
HYPR Community Narratives
AN
Fair Value US$1.65 37.9% undervalued intrinsic discount
HYPR: International Approvals And Expanded Use Will Drive Upside Momentum
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
Fair Value US$2 48.8% undervalued intrinsic discount
Global Aging And Telemedicine Will Drive Portable MRI Adoption
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$0.85 20.6% overvalued intrinsic discount
Supply Disruptions And Delayed Adoption Will Undermine Long-Term Outlook
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
HYPR: International Approvals And Expanded Use Will Drive Upside Momentum
Key Takeaways Valuation relies on aggressive assumptions of rapid adoption, strong pricing power, and seamless international expansion amid demographic and healthcare trends. Sustained growth expectations are vulnerable to delays, competitive innovation, regulatory headwinds, or setbacks in technological integration and payer acceptance.Read more
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
US$1.65
37.9% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
46.56% p.a.
Profit Margin
13.38%
Future PE
55.09x
Share price in 2028
US$1.3
Global Aging And Telemedicine Will Drive Portable MRI Adoption
Key Takeaways Rapid clinical adoption, global expansion, and unique use-cases position Swoop for outsized revenue growth and transformative market share gains over traditional MRI. Strong network effects, recurring high-margin revenue, and scalable operations suggest substantial improvement in operating margins and long-term profitability.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$2
48.8% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
31.02% p.a.
Profit Margin
12.32%
Future PE
79.46x
Share price in 2028
US$2.42
Supply Disruptions And Delayed Adoption Will Undermine Long-Term Outlook
Key Takeaways Weak differentiation, high costs, and market resistance threaten sustained adoption, limiting pricing power, recurring revenue, and delaying profitability. Supply chain risks, regulatory challenges, and competition from alternative technologies could further constrain market size, margin recovery, and overall earnings growth.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$0.85
20.6% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
30.86% p.a.
Profit Margin
12.49%
Future PE
33.52x
Share price in 2028
US$1.03
Recently Updated Narratives
AN
HYPR: International Approvals And Expanded Use Will Drive Upside Momentum
Fair Value: US$1.65 37.9% undervalued intrinsic discount
7 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Supply Disruptions And Delayed Adoption Will Undermine Long-Term Outlook
Fair Value: US$0.85 20.6% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Global Aging And Telemedicine Will Drive Portable MRI Adoption
Fair Value: US$2 48.8% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Hyperfine, Inc. Key Details
About HYPR
- Founded
- 2014
- Employees
- 111
- CEO
- WebsiteView website
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, New Zealand, and internationally. The company was founded in 2014 and is based in Guilford, Connecticut.
